*Result*: Ruxolitinib for the treatment of patients with steroid-refractory GVHD
*Title*:
Ruxolitinib for the treatment of patients with steroid-refractory GVHD : : an introduction to the REACH trials
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2019
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Immunotherapy. - 10, 5 (2018) , 391-402, ISSN: 1750-7448
*DOI*:
10.2217/imt-2017-0156